BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025
BiomX Inc. (NYSE American: PHGE), a clinical-stage company focused on developing natural and engineered phage therapies targeting specific pathogenic bacteria, has scheduled its first quarter 2025 financial results conference call and webcast for Thursday, May 15, 2025, at 2:00 p.m. ET. During the call, the company will discuss Q1 2025 financial performance and provide updates on its business operations and programs. Interested participants can join via phone by dialing 1-877-407-0724 (U.S.) or +1 201-389-0898 (International). The webcast will be accessible through the Investors section of BiomX's website at www.biomx.com, where it will also be archived for future viewing.
BiomX Inc. (NYSE American: PHGE), un'azienda in fase clinica specializzata nello sviluppo di terapie fagiche naturali e ingegnerizzate mirate a batteri patogeni specifici, ha programmato la sua teleconferenza e webcast sui risultati finanziari del primo trimestre 2025 per giovedì 15 maggio 2025 alle 14:00 ET. Durante la chiamata, la società discuterà delle performance finanziarie del primo trimestre 2025 e fornirà aggiornamenti sulle operazioni aziendali e sui programmi in corso. I partecipanti interessati possono partecipare telefonicamente chiamando il 1-877-407-0724 (USA) o il +1 201-389-0898 (Internazionale). Il webcast sarà disponibile nella sezione Investitori del sito web di BiomX all'indirizzo www.biomx.com, dove sarà anche archiviato per una visione futura.
BiomX Inc. (NYSE American: PHGE), una empresa en etapa clínica enfocada en desarrollar terapias fagicas naturales e ingenierizadas dirigidas a bacterias patógenas específicas, ha programado su llamada y webcast sobre los resultados financieros del primer trimestre de 2025 para el jueves 15 de mayo de 2025 a las 2:00 p.m. ET. Durante la llamada, la compañía discutirá el desempeño financiero del primer trimestre de 2025 y proporcionará actualizaciones sobre sus operaciones comerciales y programas. Los interesados pueden unirse por teléfono marcando 1-877-407-0724 (EE.UU.) o +1 201-389-0898 (Internacional). El webcast estará accesible a través de la sección de Inversores en el sitio web de BiomX en www.biomx.com, donde también quedará archivado para futuras consultas.
BiomX Inc. (NYSE American: PHGE)는 특정 병원성 박테리아를 표적으로 하는 천연 및 엔지니어드 파지 치료제를 개발하는 임상 단계 기업으로, 2025년 1분기 재무 실적 컨퍼런스 콜 및 웹캐스트를 2025년 5월 15일 목요일 오후 2시(동부시간)에 예정하고 있습니다. 콜 동안 회사는 2025년 1분기 재무 성과를 논의하고 사업 운영 및 프로그램에 대한 업데이트를 제공할 예정입니다. 관심 있는 참가자는 1-877-407-0724 (미국) 또는 +1 201-389-0898 (국제)로 전화해 참여할 수 있습니다. 웹캐스트는 BiomX 웹사이트(www.biomx.com)의 투자자 섹션을 통해 접속할 수 있으며, 향후 시청을 위해 아카이브될 예정입니다.
BiomX Inc. (NYSE American : PHGE), une entreprise en phase clinique spécialisée dans le développement de thérapies à base de phages naturels et modifiés ciblant des bactéries pathogènes spécifiques, a programmé sa conférence téléphonique et webcast des résultats financiers du premier trimestre 2025 pour le jeudi 15 mai 2025 à 14h00 heure de l'Est. Lors de cet appel, la société discutera de la performance financière du premier trimestre 2025 et fournira des mises à jour sur ses opérations commerciales et ses programmes. Les participants intéressés peuvent se joindre par téléphone en composant le 1-877-407-0724 (États-Unis) ou le +1 201-389-0898 (International). Le webcast sera accessible via la section Investisseurs du site web de BiomX à l'adresse www.biomx.com, où il sera également archivé pour une consultation ultérieure.
BiomX Inc. (NYSE American: PHGE), ein Unternehmen in der klinischen Entwicklungsphase, das sich auf die Entwicklung natürlicher und gentechnisch hergestellter Phagentherapien zur Bekämpfung spezifischer pathogener Bakterien spezialisiert hat, hat seine Telefonkonferenz und Webcast zu den Finanzergebnissen des ersten Quartals 2025 für Donnerstag, den 15. Mai 2025, um 14:00 Uhr ET angesetzt. Während des Anrufs wird das Unternehmen die Finanzergebnisse des ersten Quartals 2025 besprechen und Updates zu seinen Geschäftsaktivitäten und Programmen geben. Interessierte Teilnehmer können telefonisch unter 1-877-407-0724 (USA) oder +1 201-389-0898 (International) teilnehmen. Der Webcast ist über den Investor-Bereich der BiomX-Website unter www.biomx.com zugänglich und wird dort auch für eine spätere Ansicht archiviert.
- None.
- None.
NESS ZIONA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Thursday, May 15, 2025, at 2:00 p.m. ET, to report first quarter 2025 financial results and provide business and program updates.
To participate in the conference call, please dial 1-877-407-0724 (U.S.) or +1 201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.
About BiomX
BiomX is a clinical-stage company leading the development of natural and engineered phage cocktails and personalized phage treatments designed to target and destroy harmful bacteria for the treatment of chronic diseases with substantial unmet needs. BiomX discovers and validates proprietary bacterial targets and applies its BOLT (“BacteriOphage Lead to Treatment”) platform to customize phage compositions against these targets. For more information, please visit www.biomx.com, the content of which does not form a part of this press release.
BiomX, Inc.
Ben Cohen
Head Corporate Communications
benc@biomx.com
FAQ
When will BiomX (PHGE) report its Q1 2025 earnings?
How can I join BiomX's Q1 2025 earnings call?
What will BiomX discuss in their Q1 2025 earnings call?
Where can I find the replay of BiomX's Q1 2025 earnings webcast?
